PMID: 9192958May 1, 1997Paper

Radiotherapy of localised prostate cancer. Analysis of late treatment complications. A prospective study

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
G Borghede, H Hedelin

Abstract

To describe the late side-effects of radical radiotherapy of prostatic carcinoma and to analyse how pretreatment and treatment-related factors contribute to the toxicity. 184 patients have regularly been followed after terminated radical external beam radiotherapy treatment (70 Gy) for a mean of 46 (range 24-96) months. For registration of toxicity a modified RTOG scale was used. The Cox regression model was used for multivariate analysis. 37% of the patients had no late side-effects at all. Mild complications were reported by 53%, mainly gastrointestinal (42%) and urogenital (23%). A persistent improvement of the mild toxicity was seen in nearly half of the patients with gastrointestinal or nocturnal frequency side-effects. Only 16 (9%) patients had moderate or severe complications. The multivariate analysis revealed that the risk of posttreatment complications was strongly correlated to pretreatment presence of symptoms from the organs at risk. Posttreatment complications presenting first 3 years after irradiation were rare. Radical external beam radiotherapy (70 Gy) can be given with a low risk of severe complications. It appears reasonable to assume that the risk can be further reduced by excluding patients with gastrointes...Continue Reading

References

Sep 1, 1977·International Journal of Radiation Oncology, Biology, Physics·W J NegliaD E Johnson
Aug 1, 1991·International Journal of Radiation Oncology, Biology, Physics·S A LeibelZ Fuks
Sep 1, 1991·International Journal of Radiation Oncology, Biology, Physics·C A LawtonS R Doggett
Feb 1, 1990·International Journal of Radiation Oncology, Biology, Physics·H MameghanA Tynan
Sep 1, 1990·International Journal of Radiation Oncology, Biology, Physics·E S ZinreichS E Order
Jan 1, 1990·International Journal of Radiation Oncology, Biology, Physics·W G SmitB H van der Werf-Messing
Sep 1, 1988·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·C van HeeringenE Verbeek
Jul 1, 1988·International Journal of Radiation Oncology, Biology, Physics·F L Banker
Jan 1, 1985·International Journal of Radiation Oncology, Biology, Physics·G E HanksS Kramer
Jun 1, 1985·International Journal of Radiation Oncology, Biology, Physics·B Mittal
Dec 1, 1985·International Journal of Radiation Oncology, Biology, Physics·J D FormanS E Order
Oct 1, 1984·International Journal of Radiation Oncology, Biology, Physics·M V PilepichB J Walz
Feb 17, 1984·JAMA : the Journal of the American Medical Association·I GoldsteinR J Krane
Oct 1, 1981·International Journal of Radiation Oncology, Biology, Physics·M V PilepichF R Zivnuska
Mar 1, 1995·Scandinavian Journal of Urology and Nephrology·L GrenaboH Hedelin
Mar 1, 1994·International Journal of Radiation Oncology, Biology, Physics·C A PerezM A Lockett
Jan 1, 1993·Scandinavian Journal of Urology and Nephrology·K V Pedersen, A Herder
Apr 1, 1996·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·G Borghede, M Sullivan

❮ Previous
Next ❯

Citations

Jun 19, 2001·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·P C O'Brien
Sep 21, 2002·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Joost J NuyttensAndrew T Turrisi
Jul 1, 1999·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J W DenhamS Wright
Jun 21, 2002·European Urology·Serdar DegerStefan A Loening
Aug 6, 2002·European Urology·A ZurloUNKNOWN EORTC Radiotherapy and Genito-Urinary Tract Cancer Groups
Jun 23, 2000·International Journal of Radiation Oncology, Biology, Physics·E E YeohW Sun
Feb 19, 2002·International Journal of Radiation Oncology, Biology, Physics·Luca IncrocciPeter C Levendag
Dec 31, 2003·International Journal of Radiation Oncology, Biology, Physics·Mitchell LiuJonn Wu
Jan 23, 2010·The Journal of Sexual Medicine·Richard SadovskyLuca Incrocci
Feb 15, 2013·The Journal of Sexual Medicine·Luca Incrocci, Pernille Tine Jensen
Dec 13, 2005·BJU International·Kevin M O'Connor, John M Fitzpatrick
Aug 1, 2003·Expert Review of Pharmacoeconomics & Outcomes Research·Sven D'haeseFabio Efficace
Sep 27, 2000·Clinical Oncology : a Journal of the Royal College of Radiologists·S MaartenseJ W Leer
Jul 21, 2010·International Journal of Radiation Oncology, Biology, Physics·Renuka MalikStanley L Liauw
Oct 2, 2007·Clinical Oncology : a Journal of the Royal College of Radiologists·H J N Andreyev
Aug 30, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Shabbir M H AlibhaiMurray D Krahn
Jul 9, 2004·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·David PasquierEric Lartigau
Sep 10, 2005·Clinical Oncology : a Journal of the Royal College of Radiologists·S Putta, H J N Andreyev
Jul 18, 2008·Supportive Cancer Therapy·Martin Borg
Aug 19, 2011·Nihon Hinyōkika Gakkai zasshi. The japanese journal of urology·Eiji KikuchiMototsugu Oya
Jan 12, 2005·Cancer Investigation·Ulrike Boehmer, Richard K Babayan
Mar 30, 2004·The American Journal of Gastroenterology·Eric E K YeohF Dylan L Bartholomeusz
Mar 9, 2005·International Journal of Radiation Oncology, Biology, Physics·Stephanie T H PeetersPeter C M Koper

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.